Skip to content. Skip to main navigation.

VA Groups Join UTA iPerform Center

Monday, August 31, 2015

Fillia MakedonThe iPerform Center at The University of Texas at Arlington has signed a membership agreement with the Veterans Affairs North Texas Health Care System/Dallas VA Research Corporation in a joint effort in rehabilitation research.

The partnership seeks to develop novel programs to help veterans and their loved ones with physical, mental, or emotional issues.

“There is a significant need for expanding rehabilitation techniques for Veterans served by the VA,” said Dr. James LePage, the Associate Chief of Staff for Research and Development of VANTHCS. “Being a member of UTA's iPerform program allows us to be part of a larger network of researchers and organizations creating innovative technologies that can be used to improve veterans' quality-of-life.”

Based at the Dallas VA Medical Center, VANTHCS is the second-largest healthcare system in the U.S. Department of Veterans Affairs. VANTHCS provides care for military veterans and their families with a wide array of services, such as medicine and rehabilitation, and also acts as a major site for innovative research to improve the care for veterans. DVARC is the 501(c)(3) not-for profit medical research and education foundation centered at VANTHCS that supports scientific research, education, and rehabilitation to improve the lives of veterans and their families.

The iPerform Center, directed by Jenkins-Garrett Professor Fillia Makedon of UTA’s Computer Science and Engineering Department, is part of the National Science Foundation Industry/University Cooperative Research Program. The center’s research focuses on applications of human-computer interaction, including pervasive computing and computer-aided rehabilitation. Researchers from the VANTHCS/DVARC and the iPerform Center will develop projects to help those with rehabilitation needs improve their quality of life.

With this new partnership, the VANTHCS will be able to bring engineering into its solutions. Research as a result of this cooperation has the potential to lead to future improvements in clinical solutions that the VA provides.